SCHEMBL8183116

SCHEMBL8183116

O=C(OC(=S)NC1CCCCC1)C1CCCN1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 2/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 3/20 0.41
MAPK1 P28482 1/20 0.41
DUSP3 P51452 1/20 0.41
PTPN5 P54829 1/20 0.41
PTPN11 Q06124 1/20 0.41
EPHX1 P07099 6/20 0.40
MAPT P10636 1/20 0.39
KDM4E B2RXH2 1/20 0.39
EPHX2 P34913 1/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534211 0.84 EPHX1 (0.46) ALDH1A1CYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL9737609 0.76 NOS2 (0.43)
SCHEMBL146828 0.76 NOS2 (0.46)
SCHEMBL995604 0.76 NOS2 (0.46)
SCHEMBL6859669 0.76 NOS2 (0.46)
SCHEMBL17676973 0.75 EPHX1 (0.48) ALDH1A1CYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL9825084 0.75 EPHX1 (0.48) ALDH1A1CYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL5157107 0.75 EPHX1 (0.48) ALDH1A1CYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL7265700 0.75 EPHX1 (0.48) ALDH1A1CYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL6723813 0.75 NOS2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011650-A1 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS Amgen Inc., (US) 2000-06-28 EP disclosed
WO-1999014998-A2 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS AMGEN INC. (US) 1999-04-01 WO disclosed